http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102603784-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ee804a58319ce0278b79dd77515f741
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D505-20
filingDate 2012-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8d90b5707af2db30fd307fb081a9a98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ae10b2f8ea53bc7b0c97299ccd5908a
publicationDate 2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102603784-B
titleOfInvention A kind of latamoxefal chloride aluminum (tin) anisole complex and its preparation method and application
abstract The invention relates to an intermediate for synthesizing latamoxef and its preparation method. Said intermediate of the present invention is a class of latamoxefal aluminum chloride (tin) anisole complexes, and its preparation method is simple and easy, and separation is easy, and content, yield are high, and stability is high, and cost is low, and can be used now. It is conveniently converted into Latamoxycetide (Sodium), thereby overcoming the difficulty of insufficient purity of Synthesizing Latamoxycetide (Sodium) in the prior art. The purity of the latamoxef sodium obtained by hydrolysis of this complex as a raw material is higher than 99%, which is far higher than the standard of the Chinese Pharmacopoeia (single impurity is no more than 2%, and the total impurity is no more than 5%), and is also higher than the Japanese Pharmacopoeia standard.
priorityDate 2012-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4323567-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468187063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468187062

Total number of triples: 18.